Additionally, expression of PLSCR1 has been shown to be increased in monocytes of a subset of humans with systemic lupus erythematosus (SLE) at elevated risk for blood clotting, and in the monocytes of humans with anti-phospholipid syndrome [104, 105]. Here, PLSCR1 is linked to systemic lupus erythematosus.